Ledipasvir
Ledipasvir
Ledipasvir (pronounced leh-dih-pahs-veer) is an antiviral medication used in the treatment of hepatitis C. It is often used in combination with sofosbuvir, another antiviral medication, in a treatment known as Harvoni.
Etymology
The name "Ledipasvir" is derived from the chemical structure of the drug. The "Led" part of the name comes from the chemical group leucine, "i" stands for inhibitor, and "pasvir" is a common suffix for antiviral medications.
Usage
Ledipasvir is used in the treatment of chronic hepatitis C, a viral infection that can lead to serious liver problems including cirrhosis and liver cancer. It works by preventing the hepatitis C virus from multiplying in the body.
Related Terms
- Antiviral medication: A type of drug used to treat viral infections.
- Hepatitis C: A viral infection that causes liver disease.
- Harvoni: A combination treatment for hepatitis C that includes ledipasvir and sofosbuvir.
- Sofosbuvir: An antiviral medication used in combination with ledipasvir to treat hepatitis C.
- Cirrhosis: A condition in which the liver does not function properly due to long-term damage.
- Liver cancer: A type of cancer that begins in the cells of the liver.
External links
- Medical encyclopedia article on Ledipasvir
- Wikipedia's article - Ledipasvir
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski